Work

Abstract PD6-06: Angiogenesis contributes to chemoimmunotherapy resistance in immune-high and immune-low triple-negative breast cancer (TNBC): Biomarker analysis of the NeoPACT trial

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd6-06

Authors: P. Sharma, R. Yoder, J. M. Staley, R. Salgado, R. Madan, H. Pathak, A. K. Godwin, D. Koestler, Q. J. Khan, J. O'Shaughnessy, S. R. Stecklein

Institutions: University of Kansas Medical Center, The University of Kansas Cancer Center, Ziekenhuis aan de Stroom, Texas Oncology

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129415333

Cites:

Cited by:

Related to: